Answers are grounded in this paper and cite their sources.
Data obtained retrospectively from a group of patients with chronic granulocytic leukemia provided the basis for characterizing the onset of the terminal phase of chronic granulocytic leukemia. Such characterization permits an opportunity to introduce in sufficient time new therapeutic agents for the treatment of a phase of a disease which heretofore has been refractory to conventional therapy. The suggested criteria marking the onset of the terminal phase may require revision as more information is systematically collected in the future.
No takes yet. Share an insight, caveat, or question.
Karanas et al. (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: